Assay for the Diagnosis of Macular Degeneration

Robert Doyle (Inventor)

Research output: Patent

Abstract

An assay and kit for detecting N-retinylidene-N-retinylethanolamine (A2E) in a sample that uses a lipid binding protein, such as Saposin B, to capture A2E in the sample and assist in the extraction and measurement of A2E via mass spectroscopy. A2E thus serves as a marker for macular degeneration so that the assay and kit of the invention can be used to detect the presence or severity of macular degeneration.
Original languageEnglish (US)
StatePublished - Oct 25 2017

Fingerprint

Assays
Saposins
Patents and inventions
Carrier Proteins
Spectroscopy
Lipids

Cite this

@misc{e9f18a3bd3a2488caff6fc6cf76e748f,
title = "Assay for the Diagnosis of Macular Degeneration",
abstract = "An assay and kit for detecting N-retinylidene-N-retinylethanolamine (A2E) in a sample that uses a lipid binding protein, such as Saposin B, to capture A2E in the sample and assist in the extraction and measurement of A2E via mass spectroscopy. A2E thus serves as a marker for macular degeneration so that the assay and kit of the invention can be used to detect the presence or severity of macular degeneration.",
author = "Robert Doyle",
year = "2017",
month = "10",
day = "25",
language = "English (US)",
type = "Patent",

}

TY - PAT

T1 - Assay for the Diagnosis of Macular Degeneration

AU - Doyle, Robert

PY - 2017/10/25

Y1 - 2017/10/25

N2 - An assay and kit for detecting N-retinylidene-N-retinylethanolamine (A2E) in a sample that uses a lipid binding protein, such as Saposin B, to capture A2E in the sample and assist in the extraction and measurement of A2E via mass spectroscopy. A2E thus serves as a marker for macular degeneration so that the assay and kit of the invention can be used to detect the presence or severity of macular degeneration.

AB - An assay and kit for detecting N-retinylidene-N-retinylethanolamine (A2E) in a sample that uses a lipid binding protein, such as Saposin B, to capture A2E in the sample and assist in the extraction and measurement of A2E via mass spectroscopy. A2E thus serves as a marker for macular degeneration so that the assay and kit of the invention can be used to detect the presence or severity of macular degeneration.

M3 - Patent

ER -